Sun Pharma launches CEQUA for treatment of dry eye disease in US

Sun Pharma launches CEQUA for treatment of dry eye disease in US

Source: 
Pharmaceutical Business Review
snippet: 


Sun Pharmaceutical Industries announced that one of its wholly-owned subsidiaries has commercialised CEQUA (cyclosporine ophthalmic solution) 0.09% in the US.